Filing Details

Accession Number:
0001209191-15-087211
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-29 12:11:31
Reporting Period:
2015-12-24
Filing Date:
2015-12-29
Accepted Time:
2015-12-29 12:11:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1108205 Curis Inc CRIS Biological Products, (No Disgnostic Substances) (2836) 043505116
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190121 R Daniel Passeri 4 Maguire Road
Lexington MA 02421
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-24 2,600 $1.57 201,498 No 4 M Direct
Common Stock Disposition 2015-12-24 2,600 $2.90 198,898 No 4 S Direct
Common Stock Acquisiton 2015-12-28 11,000 $1.57 209,898 No 4 M Direct
Common Stock Disposition 2015-12-28 11,000 $2.84 198,898 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee stock option Disposition 2015-12-24 2,600 $1.57 2,600 $1.57
Common Stock Employee stock option Disposition 2015-12-28 11,000 $1.57 11,000 $1.57
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-05-31 2016-05-31 No 4 M Direct
0 2010-05-31 2016-05-31 No 4 M Direct
Footnotes
  1. These shares were sold between $2.85-$2.95/share pursuant to an effective 10b5-1 plan. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.
  2. These shares were sold between $2.80-$2.91/share pursuant to an effective 10b5-1 plan. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.
  3. Options vested over a four-year period and became fully vested on May 31, 2010.